Global Lysosomal Storage Disease Treatment Market Report By Indication (Gaucher's Diseases, Fabry Diseases, Pompe’s Syndrome, Mucopolysaccharidosis, Others), By Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy, Others), By End User (Hospitals, Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212134
April 2020
Report Formats:

The global demand for Lysosomal Storage Disease Treatment Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Lysosomal Storage Disease Treatment is a set of procedures used to treat rare genetic disorders caused by lysosomal storage defects. The lysosomal defects are caused by the deficit of certain enzymes in the human body which can cause damage to body cells and organs. It encompasses around 50 different diseases. The various treatment procedures available are stem cell transplant, substrate reduction therapy and enzyme replacement therapies. LSDs cannot be cured but early detection can reduce its impact. Some of the common LSDs are batten disease, Fabry disease and cystinosis and they have varied symptoms.
 
Market Dynamics
 
The growing number of people with lysosomal disorders and increased awareness about the various treatment options available will be the major drivers for this market. Enhanced diagnosis and rise in research and development activities for treating LSD will boost the growth of this market. Stem cell transplant is a certain treatment method used to treat LSD and advanced research in this area will further propel the market growth. A rise in the storage of stem cells will greatly benefit market growth. COVID-19 pandemic will not impact this market since LSDs are genetic disorders unaffected by viruses. The major hindrances of this market are high treatment cost and many undiagnosed cases due to its heterogeneous nature.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of lysosomal storage disease treatment.
 
Market Segmentation
 
The entire lysosomal storage disease treatment market has been sub-categorized into indication, type of therapy and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Indication

  • Gaucher's Diseases
  • Fabry Diseases
  • Pompe’s Syndrome
  • Mucopolysaccharidosis
  • Others
 
By Type of Therapy
  • Enzyme Replacement Therapy
  • Stem Cell Therapy
  • Substrate Reduction Therapy
  • Others
 
By End User
  • Hospitals
  • Clinics
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for lysosomal storage disease treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Lysosomal Storage Disease Treatment Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lysosomal storage disease treatment market include Shire PLC, Pfizer, Inc., Sanofi, BioMarin Pharmaceutical Inc., Actelion Ltd., Raptor Pharmaceutical Corp., ProtalixBiotherapeutics Inc., Amicus Therapeutics, Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Lysosomal Storage Disease Treatment Market
       2.2. Global Lysosomal Storage Disease Treatment Market Snapshot
 
3 . LYSOSOMAL STORAGE DISEASE TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Lysosomal Storage Disease Treatment Market
       3.3. Market Restraints of Lysosomal Storage Disease Treatment Market
       3.4. Opportunities of Lysosomal Storage Disease Treatment Market
       3.5. Trends of Lysosomal Storage Disease Treatment Market
       3.6. Porter’s Five Force Analysis of Lysosomal Storage Disease Treatment Market
       3.7. Lysosomal Storage Disease Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Indication
           3.7.2 Market Attractive Analysis by Type of Therapy
           3.7.3 Market Attractive Analysis by End User
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Lysosomal Storage Disease Treatment Value Chain Analysis
       4.2. Lysosomal Storage Disease Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Lysosomal Storage Disease Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Lysosomal Storage Disease Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Lysosomal Storage Disease Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Lysosomal Storage Disease Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Lysosomal Storage Disease Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Lysosomal Storage Disease Treatment Market
 
6 . GLOBAL LYSOSOMAL STORAGE DISEASE TREATMENT MARKET ANALYSIS BY INDICATION
       6.1 Overview by Indication
       6.2 Global Lysosomal Storage Disease Treatment Market Analysis by Indication
       6.3 Market Analysis of Gaucher's Diseases by Regions
       6.4 Market Analysis of Fabry Diseases by Regions
       6.6 Market Analysis of Pompe’s Syndrome by Regions
       6.5 Market Analysis of Mucopolysaccharidosis by Regions
       6.7 Market Analysis of Others by Regions
 
7 . GLOBAL LYSOSOMAL STORAGE DISEASE TREATMENT MARKET ANALYSIS BY TYPE OF THERAPY
       7.1 Overview by Type of Therapy
       7.2 Global Lysosomal Storage Disease Treatment Market Analysis by Type of Therapy
       7.3 Market Analysis of Enzyme Replacement Therapy by Regions
       7.4 Market Analysis of Stem Cell Therapy by Regions
       7.5 Market Analysis of Substrate Reduction Therapy by Regions
       7.6 Market Analysis of Others by Regions
 
8 . GLOBAL LYSOSOMAL STORAGE DISEASE TREATMENT MARKET ANALYSIS BY END USER
       8.1 Overview by End User
       8.2 Global Lysosomal Storage Disease Treatment Market Analysis by End User
       8.3 Market Analysis of Hospitals by Regions
       8.4 Market Analysis of Clinics by Regions
 
9 . GLOBAL LYSOSOMAL STORAGE DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Lysosomal Storage Disease Treatment Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Lysosomal Storage Disease Treatment Market Estimate by Market Segment
           9.4.3. Europe Lysosomal Storage Disease Treatment Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by Market Segment
           9.5.3. Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Lysosomal Storage Disease Treatment Market Estimate by Market Segment
           9.6.3. Latin America Lysosomal Storage Disease Treatment Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Lysosomal Storage Disease Treatment Market Estimate by Market Segment
           9.7.3. Middle East & Africa Lysosomal Storage Disease Treatment Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE LYSOSOMAL STORAGE DISEASE TREATMENT COMPANIES
       10.1. Lysosomal Storage Disease Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF LYSOSOMAL STORAGE DISEASE TREATMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Shire PLC
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Pfizer, Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Sanofi
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. BioMarin Pharmaceutical Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Actelion Ltd.
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Raptor Pharmaceutical Corp.
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. ProtalixBiotherapeutics Inc.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Amicus Therapeutics, Inc.
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Lysosomal Storage Disease Treatment Market Snapshot
  • Drivers of The Global Lysosomal Storage Disease Treatment Market Impact Analysis
  • Restraints of The Global Lysosomal Storage Disease Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Lysosomal Storage Disease Treatment Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Lysosomal Storage Disease Treatment Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Lysosomal Storage Disease Treatment Market
  • Global Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Gaucher's Diseases by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Fabry Diseases by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Pompe’s Syndrome by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Mucopolysaccharidosis by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Others by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis by Type of Therapy (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Enzyme Replacement Therapy by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Stem Cell Therapy by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Substrate Reduction Therapy by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Others by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis by End User (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Hospitals by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Clinics by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market by Geography (USD MN)
  • North America Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • North America Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • North America Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • North America Lysosomal Storage Disease Treatment Market Estimate by Country (USD MN)
  • United State Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • United State Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • United State Lysosomal Storage Disease Treatment Market Analysis by End User (USD MN)
  • Rest of North America Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Rest of North America Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Rest of North America Lysosomal Storage Disease Treatment Market Estimate by End User(USD MN)
  • Europe Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Europe Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Europe Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • United Kingdom Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • United Kingdom Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • United Kingdom Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • France Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • France Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • France Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Germany Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Germany Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Germany Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Rest of Europe Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Rest of Europe Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Rest of Europe Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Asia Pacific Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by Country (USD MN)
  • China Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • China Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • China Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Japan Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Japan Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Japan Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • India Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • India Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • India Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Rest of Asia Pacific Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Rest of Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Rest of Asia Pacific Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Latin America Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Latin America Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Latin America Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Latin America Lysosomal Storage Disease Treatment Market Estimate by Country (USD MN)
  • Brazil Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Brazil Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Brazil Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Rest of Latin America Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Rest of Latin America Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Rest of Latin America Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Middle East & Africa Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Middle East & Africa Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Middle East & Africa Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Middle East & Africa Lysosomal Storage Disease Treatment Market Estimate by Country (USD MN)
  • Middle East Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Middle East Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Middle East Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Africa Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Africa Lysosomal Storage Disease Treatment Market Estimate by Type of Therapy (USD MN)
  • Africa Lysosomal Storage Disease Treatment Market Estimate by End User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Lysosomal Storage Disease Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Lysosomal Storage Disease Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Type of Therapy
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Lysosomal Storage Disease Treatment Market Analysis by Indication (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Gaucher's Diseases by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Fabry Diseases by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Pompe’s Syndrome by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Mucopolysaccharidosis by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Others by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis by Type of Therapy (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Enzyme Replacement Therapy by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Stem Cell Therapy by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Substrate Reduction Therapy by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Others by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis by End User (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Hospitals by Geography (USD MN)
  • Global Lysosomal Storage Disease Treatment Market Analysis in Clinics by Geography (USD MN)
  • Latin America Lysosomal Storage Disease Treatment Market by Revenue
  • Middle East & Africa Lysosomal Storage Disease Treatment Market by Revenue
  • Recent Development in Lysosomal Storage Disease Treatment Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials